Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 HKD | +0.98% | +11.34% | +18.71% |
Apr. 26 | Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA | MT |
Apr. 24 | Shanghai Henlius Biotech Doses 1st Patient in Fibrosis Drug Clinical Study in China | MT |
Chart calendar Shanghai Henlius Biotech, Inc.
Upcoming events on Shanghai Henlius Biotech, Inc.
Past events on Shanghai Henlius Biotech, Inc.
2024-03-21 07:47 am | Q4 2023 Earnings Release |
2023-11-15 07:10 am | Q3 2023 Earnings Release |
2023-08-28 03:30 am | Extraordinary Shareholders Meeting |
2023-08-25 07:26 am | Q2 2023 Earnings Release |
2023-05-25 02:00 am | Annual General Meeting |
2023-03-30 | Q4 2022 Earnings Release |
2022-08-17 | Interim 2022 Earnings Release |
2022-03-15 | FY 2021 Earnings Release |
2021-09-28 03:00 am | Chinese Society of Clinical Oncology Meeting - Zhenggang Ren, Zhongshan Hospital |
2021-09-26 05:15 am | Chinese Society of Clinical Oncology Meeting - Ye Guo, Shanghai East Hospital |
2021-09-26 03:24 am | Chinese Society of Clinical Oncology Meeting - Jusheng An Cancer Hospital Chinese Academy of Medical |
2021-09-25 10:27 pm | Chinese Society of Clinical Oncology Meeting - Ye Guo Shanghai East Hospital |
2021-08-17 | Interim 2021 Earnings Release |
2021-01-19 | UBS Greater China Conference |
2021-01-13 | Citigroup Greater China Healthcare Corporate Day |
2021-01-12 | JP Morgan Healthcare Conference |
2020-08-23 | Interim 2020 Earnings Release |
2020-06-12 03:30 am | Extraordinary Shareholders Meeting |
2020-03-22 | FY 2019 Earnings Release |
2020-02-18 08:00 pm | Extraordinary Shareholders Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 90,9 107 -15.35% | 588 584 0.67% | 1 682 1 530 9.98% | 3 215 3 039 5.8% | 5 395 5 075 6.29% | 5 894 |
EBITDA Million CNY | Released Forecast Spread | -769 -619 -24.21% | -858 -695 -23.4% | -420 -438 4.21% | -311 165 -288.25% | 1 021 873 17% | 1 074 |
EBIT Million CNY | Released Forecast Spread | -851 -651 -30.74% | -994 -792 -25.51% | -620 -606 -2.37% | -324 -640 49.41% | 662 594 11.37% | 759 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -875 -536 -63.21% | -994 -792 -25.41% | -957 -678 -41.2% | -694 -365 -90.13% | 570 479 18.88% | 677 |
Net income Million CNY | Released Forecast Spread | -875 -607 -44.22% | -994 -765 -29.82% | -984 -678 -45.23% | -695 -366 -89.99% | 546 466 17.26% | 600 |
EPS CNY | Released Forecast Spread | -1,76 -1,30 -34.95% | -1,88 -1,50 -25.48% | -1,83 -1,19 -53.98% | -1,28 -0,74 -72.97% | 1,00 0,86 16.06% | 1,12 |
Announcement Date | 23/03/20 | 26/03/21 | 16/03/22 | 31/03/23 | 21/03/24 | - |
Past sector events for Shanghai Henlius Biotech, Inc.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2696 Stock
- Calendar Shanghai Henlius Biotech, Inc.